Sanofi cuts 466 jobs, all ties to new CV research

French drugmaker Sanofi is cutting 466 jobs as part of an R&D “reshuffle” that will also put an end to the company’s new research efforts in cardiology, Reuters reports.

A spokesperson said on June 19 the reorganization of Sanofi’s R&D department will allow the company to concentrate its research efforts on cancer, immunology, rare diseases and vaccines. While that means Sanofi is putting a halt to any new research in cardiology, its existing CV research programs will remain intact.

The 466 job cuts will be implemented on a voluntary basis, according to Reuters. Right now, Sanofi employs 15,000 R&D workers worldwide.

Read the story below:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup